A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction.
The 2025 VA/DoD lipid management guideline recommends more intensive therapy for high-risk patients, including combination treatments and new risk assessment tools.
- Why it matters: Effective lipid management is crucial for reducing cardiovascular disease risk, yet gaps remain in risk stratification and treatment approaches, especially for diverse populations.
- What they did: The guideline update involved systematic review of literature from 2019 to 2025, developing 24 evidence-based recommendations, including new risk calculators, testing strategies, and treatment options for various risk levels.
- The result: Implementing these updates enables personalized, evidence-based lipid management, potentially improving cardiovascular outcomes through refined risk assessment and tailored therapies.